Clinical Trial Update: Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tacrolimus sustained-release capsules for induction therapy in lupus nephritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Tacrolimus sustained-release capsules (Tacrolimus)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lupus Nephritis | Phase 3 | Status: WITHDRAWN